All Stories

  1. Benchmarking inflammation-nutrition and TyG-related indices for 5-year mortality risk in adults with questionnaire-defined obstructive sleep apnea: a survey-weighted NHANES derivation cohort with multicenter external validation
  2. Natural Products as Therapeutics for Lung and Respiratory Diseases
  3. Multitarget docking and molecular enumeration reveal DdpMPyPEPhU as a potent modulator of cell cycle, glucocorticoid, and estrogen signalling in breast cancer
  4. Multimodal evaluation of mannose engineered poly lactic glycolic acid nanoparticles with granulocyte colony stimulating factor focused delivery to bone marrow for neutropenia
  5. Artificial intelligence in molecular screening: Advances, challenges, and future perspectives
  6. Artificial intelligence in multi-omics integration for precision drug design
  7. DrLungker: A Deep Ensemble Learning Framework for Predicting Anti‐Lung Cancer Compound Activity and Validating Multitarget Potency through WaterMap, DFT, MD Simulations, and MM‐GBSA Analysis
  8. Evaluating the polypharmacological potential of cosmetic preservative Imidurea against Lung Cancer-associated EGFR, CDK2, STAT3, BCL2, p53, and ABCB1 proteins
  9. Machine learning for genomic profiling and drug discovery in personalised lung cancer therapeutics
  10. Integrative computational approaches identify haptoglobin inhibitors to modulate erythrocyte sedimentation rate in trauma-linked inflammatory and haematological malignancies
  11. FDA-approved Levophed as an alternative multitargeted therapeutic against cervical cancer transferase, cell cycle, and regulatory proteins
  12. Evaluating the polypharmacological potency of FEDPN from ChEMBL BioAssays against lung cancer EGFR, ALK, TrkA and KRAS proteins
  13. Probing the multitargeted potency of Theodrenaline and its comparative evaluation with Crizotinib against transferase, hydrolase, signalling, and apoptosis-related proteins to overcome lung cancer drug resistance
  14. Molecular dynamics simulation and docking studies reveals inhibition of NF-kB signaling as a promising therapeutic drug target for reduction in cytokines storms
  15. Synthesis, structural elucidation, and antibacterial activities of novel copper(II), cobalt(II), and nickel(II) complexes with a bidentate Schiff base ligand against pathogenic bacteria
  16. Investigating the Inhibitory Effects of Paliperidone on RAGEs: Docking, DFT, MD Simulations, MMPBSA, MTT, Apoptosis, and Immunoblotting Studies
  17. Contributors
  18. Deep learning in variant detection and annotation
  19. RCSB Protein Data Bank: revolutionising drug discovery and design for over five decades
  20. Reporting multitargeted potency of Tiaprofenic acid against lung cancer: Molecular fingerprinting, MD simulation, and MTT-based cell viability assay studies
  21. Meet the Executive Guest Editor
  22. 2-hydrazinobenzothiazole based derivatives: Synthesis, characterization, antifungal, DNA binding and molecular modelling approaches
  23. Microbial Biofilm Inhibition Using Magnetic Cross-Linked Polyphenol Oxidase Aggregates
  24. An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives
  25. Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis
  26. Bedeutende Innovationen in naturinspirierten intelligenten Computertechniken zur Identifizierung von Biomarkern und potenziellen therapeutischen Mitteln
  27. Beispielhafte Implikationen von naturinspirierten Berechnungsmethoden auf Therapeutika und computergestützte Arzneimittelentwicklung
  28. Deciphering the influenza neuraminidase inhibitory potential of naturally occurring biflavonoids: An in silico approach
  29. Application of machine learning–based approaches in stem cell research
  30. Artificial Bee Colony Algorithms in Gene Expression Studies: A Case Study
  31. Deep learning in computer-aided drug design: a case study
  32. Generative AI in Drug Designing: Current State-of-the-Art and Perspectives
  33. Investigating the multitargeted anti-diabetic potential of cucurbitane-type triterpenoid from Momordica charantia : an LC-MS, docking-based MM\GBSA and MD simulation study
  34. In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma
  35. Synthesis, single crystal, TD-DFT, molecular dynamics simulation and DNA binding studies of carbothioamide analog
  36. Structural–functional analysis and molecular characterization of arsenate reductase from Enterobacter cloacae RSC3 for arsenic biotransformation
  37. Computational screening and MM/GBSA-based MD simulation studies reveal the high binding potential of FDA-approved drugs against Cutibacterium acnes sialidase
  38. Structure-Based Design of Novel MAO-B Inhibitors: A Review
  39. Comparative genomic assessment of members of genus Tenacibaculum: an exploratory study
  40. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and in-vitro study
  41. Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study
  42. Structure-based virtual screening, molecular docking, molecular dynamics simulation, and metabolic reactivity studies of quinazoline derivatives for their anti-EGFR activity against tumor angiogenesis
  43. Multialgorithm-Based Docking Reveals Imidazolidinyl Urea as a Multitargeted Inhibitor for Lung Cancer
  44. Comprehensive Computational Studies of Naturally Occurring Kuguacins as Antidiabetic Agents by Targeting Visfatin
  45. Therapeutic Protein-Based Vaccines
  46. Nanoinformatics and nanomodeling: Recent developments in computational nanodrug design and delivery systems
  47. Design, synthesis, X-ray crystal structures, anticancer, DNA binding, and molecular modelling studies of pyrazole–pyrazoline hybrid derivatives
  48. Natural Product-Based Drug Designing for Treatment of Human Parasitic Diseases
  49. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against Cervical Cancer
  50. Consequential Innovations in Nature-Inspired Intelligent Computing Techniques for Biomarkers and Potential Therapeutics Identification
  51. Illustrious Implications of Nature-Inspired Computing Methods in Therapeutics and Computer-Aided Drug Design
  52. SARS-CoV-2 Variants Show a Gradual Declining Pathogenicity and Pro-Inflammatory Cytokine Stimulation, an Increasing Antigenic and Anti-Inflammatory Cytokine Induction, and Rising Structural Protein Instability: A Minimal Number Genome-Based Approach
  53. Comparative insight into rice chloroplasts genome: mutational phylogenomics reveals Echinochloa oryzicola as the ongoing progenitor of rice
  54. In-silico and in-vitro study reveals Ziprasidone as a potential aromatase inhibitor against breast carcinoma
  55. Macrophage-Targeted Punicalagin Nanoengineering to Alleviate Methotrexate-Induced Neutropenia: A Molecular Docking, DFT, and MD Simulation Analysis
  56. Unveiling the multitargeted potential of N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine (NSL-CG) against SARS CoV-2: a virtual screening and molecular dynamics simulation study
  57. In silico Analysis of ACE2 Receptor to Find Potential Herbal Drugs in COVID-19 Associated Neurological Dysfunctions
  58. In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2
  59. Multitargeted Molecular Dynamic Understanding of Butoxypheser Against SARS-CoV-2: An in Silico Study
  60. Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: anin-silicostudy
  61. Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
  62. Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid
  63. Antiviral Potential of Indian Medicinal Plants Against Influenza and SARS-CoV: A Systematic Review
  64. Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2
  65. Fundamentals of molecular modeling in drug design
  66. The Incipient Role of Computational Intelligence in Oncology: Drug Designing, Discovery, and Development
  67. Correction to: Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis
  68. Clinical Applications of Next-Generation Sequence Analysis in Acute Myelogenous Leukemia
  69. Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis
  70. Mitogen-Activated Protein Kinase, Plants, and Heat Stress
  71. Exosomes as an emerging nanoplatform for functional therapeutics
  72. From molecules to patients: the clinical applications of biological databases and electronic health records
  73. A Review on Predictive Systems and Data Models for COVID-19
  74. Mobile Technology Solution for COVID-19: Surveillance and Prevention
  75. Human BLK tyrosine protein kinase is closely related to Pongo Albelli : An in silico structural and functional analysis
  76. Probing the effect of a plus 1bp frameshift mutation in protein-DNA interface of domestication gene, NAMB1, in wheat